HCWB HCW Biologics Inc
Price (delayed)
$0.2817
Market cap
$12.66M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.77
Enterprise value
$21.68M
Highlights
HCW Biologics's equity has plunged by 150% YoY but it has increased by 32% from the previous quarter
HCW Biologics's gross profit has soared by 71% YoY but it has decreased by 15% from the previous quarter
The company's debt has surged by 117% YoY and by 7% QoQ
HCW Biologics's quick ratio has shrunk by 69% YoY
Key stats
What are the main financial stats of HCWB
Market
Valuations
Earnings
Shares outstanding
44.93M
Market cap
$12.66M
Enterprise value
$21.68M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
11.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
22.59
Revenue
$959,403
Gross profit
$959,403
Operating income
-$29.48M
Net income
-$30.02M
EBIT
-$29.39M
EBITDA
-$28.21M
Free cash flow
-$14.49M
Per share
Balance sheet
Liquidity
EPS
-$0.77
EPS diluted
-$0.77
Free cash flow per share
-$0.37
Book value per share
-$0.18
Revenue per share
$0.02
TBVPS
$0.78
Total assets
$30.24M
Total liabilities
$37.01M
Debt
$13.69M
Equity
-$6.77M
Working capital
-$23.93M
Debt to equity
-2.02
Current ratio
0.19
Quick ratio
0.18
Net debt/EBITDA
-0.32
Margins
Efficiency
Dividend
EBITDA margin
-2,940.2%
Gross margin
100%
Net margin
-3,129.4%
Operating margin
-3,072.7%
Return on assets
-105.3%
Return on equity
N/A
Return on invested capital
-228.4%
Return on capital employed
-4,836.8%
Return on sales
-3,063.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HCWB stock price
How has the HCW Biologics stock price performed over time
Intraday
0.28%
1 week
-6.78%
1 month
-25.91%
1 year
-83.03%
YTD
-36.85%
QTD
-0.14%
Financial performance
How have HCW Biologics's revenue and profit performed over time
Revenue
$959,403
Gross profit
$959,403
Operating income
-$29.48M
Net income
-$30.02M
Gross margin
100%
Net margin
-3,129.4%
HCW Biologics's gross profit has soared by 71% YoY but it has decreased by 15% from the previous quarter
HCWB's revenue has surged by 71% year-on-year but it is down by 15% since the previous quarter
HCWB's operating margin is up by 33% YoY and by 2.7% from the previous quarter
The company's net margin rose by 30% YoY and by 5% QoQ
Growth
What is HCW Biologics's growth rate over time
Valuation
What is HCW Biologics stock price valuation
P/E
N/A
P/B
N/A
P/S
11.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
22.59
HCWB's EPS is up by 23% since the previous quarter but it is down by 10% year-on-year
HCW Biologics's equity has plunged by 150% YoY but it has increased by 32% from the previous quarter
HCWB's revenue has surged by 71% year-on-year but it is down by 15% since the previous quarter
HCWB's price to sales (P/S) is 59% less than its last 4 quarters average of 28.0
Efficiency
How efficient is HCW Biologics business performance
HCWB's return on invested capital has dropped by 151% year-on-year
The ROA has shrunk by 55% YoY but it is up by 21% QoQ
HCWB's ROS is up by 31% year-on-year and by 6% since the previous quarter
Dividends
What is HCWB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HCWB.
Financial health
How did HCW Biologics financials performed over time
HCWB's total assets is 18% smaller than its total liabilities
The company's current ratio has surged by 171% QoQ but it has shrunk by 74% YoY
HCWB's total liabilities has soared by 146% YoY
HCW Biologics's equity has plunged by 150% YoY but it has increased by 32% from the previous quarter
The company's debt has surged by 117% YoY and by 7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.